What changed in this filing

/stocks — the workspaceLOADING

Item 1. Financial Statements

2026-08-07 compared with 2026-05-08 · 109 added, 64 removed, 338 unchanged (34% of the section changed)

4 unchanged sentences

Three Months Ended

June 30, Six Months Ended

2026 2025 2026 2025

Sales $ 421,284 $ 410,022 $ 825,468 $ 787,813

19 unchanged sentences

Three Months Ended

June 30, Six Months Ended

2026 2025 2026 2025

Net income (loss) $ 3,248 $ 31,371 $ ( 12,298 ) $ 54,715

1 unchanged sentence

Cash-flow hedges — — — 7

Other comprehensive income, net of tax 8 18

Other comprehensive income (loss), net of tax ( 22 ) 24 ( 14 ) 42

Comprehensive income (loss) $ 3,226 $ 31,395 $ ( 12,312 ) $ 54,757

33 unchanged sentences

200,000,000 shares authorized;

33,345,325 shares issued and 26,959,036 outstanding at March 31, 2026;

33,393,066 shares issued and 27,001,186 outstanding at June 30, 2026;

33,177,824 shares issued and 26,864,035 outstanding at December 31, 2025

Preferred stock, par value $ 0.01 ;

50,000,000 shares authorized and 0 shares issued and outstanding at March 31, 2026 and December 31, 2025

Treasury stock at par ( 6,386,289 shares at March 31, 2026;

50,000,000 shares authorized and 0 shares issued and outstanding at June 30, 2026 and December 31, 2025

Treasury stock at par ( 6,391,880 shares at June 30, 2026;

6,313,789 shares at December 31, 2025)

9 unchanged sentences

(Dollars in thousands)

Three Months Ended

Six Months Ended

Cash flows from operating activities:

53 unchanged sentences

Balance at March 31, 2026 33,345,325 334 144,066 642,949 ( 64 ) 9,004 796,289

Net income — — — 3,248 — — 3,248

Comprehensive income

Foreign exchange translation adjustments — — — — — ( 22 ) ( 22 )

Other comprehensive loss, net of tax — — — — — ( 22 ) ( 22 )

Issuance of common stock 47,741 — — — — — —

Purchase of treasury stock ( 5,591 shares)

— — ( 122 ) — — — ( 122 )

Stock-based compensation — — 1,833 — — — 1,833

Dividends — — 214 ( 4,528 ) — — ( 4,314 )

Balance at June 30, 2026 33,393,066 $ 334 $ 145,991 $ 641,669 $ ( 64 ) $ 8,982 $ 796,912

ADVANSIX INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Dollars in thousands)

Common Stock Additional Paid-In Capital Retained Earnings Treasury Stock Accumulated Other Comprehensive Income (Loss) Total Equity

12 unchanged sentences

Balance at March 31, 2025 33,113,379 331 137,677 650,435 ( 63 ) 5,988 794,368

Net income — — — 31,371 — — 31,371

Comprehensive income

Foreign exchange translation adjustments — — — — — 24 24

Other comprehensive loss, net of tax — — — — — 24 24

Issuance of common stock 38,907 1 — — — — 1

Purchase of treasury stock ( 2,538 shares)

— — ( 51 ) — — — ( 51 )

Stock-based compensation — — 2,309 — — — 2,309

Dividends — — 162 ( 4,452 ) — — ( 4,290 )

Balance at June 30, 2025 33,152,286 $ 332 $ 140,097 $ 677,354 $ ( 63 ) $ 6,012 $ 823,732

See accompanying notes to Condensed Consolidated Financial Statements.

13 unchanged sentences

GAAP for complete financial statements.

In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the Company's financial position as of March 31, 2026, and its results of operations for the three months ended March 31, 2026 and 2025 and cash flows for the three months ended March 31, 2026 and 2025.

In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the Company's financial position as of June 30, 2026, and its results of operations for the three and six months ended June 30, 2026 and 2025 and cash flows for the six months ended June 30, 2026 and 2025.

The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements but does not include all disclosures required by U.S.

6 unchanged sentences

In the event that differences in actual closing dates are material to year-over-year comparisons of quarterly or year-to-date results, we will provide the appropriate disclosures.

Our actual closing dates for the three months ended March 31, 2026 and 2025 were April 4, 2026 and March 29, 2025, respectively, which resulted in six additional reporting days in the current year period from our normal quarterly closing procedures.

Liabilities to creditors to whom we have issued checks that remained outstanding at March 31, 2026 and December 31, 2025 aggregated to $ 9.0 million and $ 4.9 million, respectively.

Our actual closing dates for the three and six months ended June 30, 2026 and 2025 were July 4, 2026 and June 28, 2025, respectively, which resulted in six additional reporting days in the six month period from our normal quarterly closing procedures.

Liabilities to creditors to whom we have issued checks that remained outstanding at June 30, 2026 and December 31, 2025 aggregated to $ 3.4 million and $ 4.9 million, respectively.

These were included in Cash and cash equivalents and Accounts payable in the Condensed Consolidated Balance Sheets.

As of March 31, 2026, the Company has repurchased a total of 6,386,289 shares of common stock, including 1,140,833 shares withheld to cover tax withholding obligations in connection with the vesting of awards, for an aggregate of $ 195.4 million at a weighted average market price of $ 30.59 per share.

As of March 31, 2026, approximately $ 62.0 million remained available for share repurchases under the current authorization approved by the Company's Board of Directors (the "Board") on February 17, 2023.

During the period April 1, 2026 through May 1, 2026, no additional shares were repurchased for tax withholding obligations or under the currently authorized repurchase program.

As of June 30, 2026, the Company has repurchased a total of 6,391,880 shares of common stock, including 1,146,424 shares withheld to cover tax withholding obligations in connection with the vesting of awards, for an aggregate of $ 195.5 million at a weighted average market price of $ 30.58 per share.

As of June 30, 2026, approximately $ 62.0 million remained available for share repurchases under the current authorization approved by the Company's Board of Directors (the "Board") on February 17, 2023.

The Company has no t repurchased any shares under the currently authorized repurchase program since June 2024.

During the period July 1, 2026 through July 31, 2026, no additional shares were repurchased for tax withholding obligations or under the repurchase program.

Repurchases may be made from time to time on the open market in accordance with Rule 10b-18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including through the use of trading plans intended to qualify under Rule 10b5-1 of the Exchange Act.

28 unchanged sentences

The Company is evaluating the pronouncement and does not expect adoption to have a material impact on its consolidated financial position or results of operations.

In August 2025, the FASB issued ASU 2025-05, Financial Instruments – Credit Losses (Topic 326):

Practical Expedient for Measuring Expected Credit Losses on Certain Financial Assets.

The amendments in this ASU provide a simplified approach for estimating credit losses on certain financial assets, including current accounts receivable, by permitting entities to elect a practical expedient when measuring expected credit losses.

Under current guidance, when estimating expected credit losses, an entity must (1) consider not only historical loss experience but also adjust that information to reflect current conditions and reasonable and supportable forecasts and (2) include a measure of expected credit loss even if that risk is remote.

The amendments in this ASU allow an entity, as a practical expedient, to:

(1) Assume that current conditions as of the balance sheet date will remain unchanged over the remaining life of the financial asset;

and (2) continue to adjust historical loss information to reflect current conditions to the extent that historical information does not already do so.

The amendments are effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual periods.

The Company adopted ASU 2025-05 effective January 1, 2026.

The adoption did not have a material impact on the Company's consolidated financial position or results of operations.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40):

6 unchanged sentences

(3) disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively;

and (4) disclose the total amount of selling expense and, in annual reporting

ADVANSIX INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts and as otherwise noted)

periods, an entity's definition of selling expense.

and (4) disclose the total amount of selling expense and, in annual reporting periods, an entity's definition of selling expense.

The guidance is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027.

3 unchanged sentences

Revenue Recognition

ADVANSIX INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts and as otherwise noted)

AdvanSix serves approximately 375 customers annually, primarily in the United States, spanning a wide variety of industries worldwide.

For each of the three months ended March 31, 2026 and 2025, the Company's ten largest customers accounted for approximately 38 % of total sales.

For the three months ended June 30, 2026 and 2025, the Company's ten largest customers accounted for approximately 36 % and 43 % of total sales, respectively.

For the six months ended June 30, 2026 and 2025, the Company's ten largest customers accounted for approximately 36 % and 39 % of total sales, respectively.

We typically sell to customers under master service agreements, with primarily one-year terms, or by purchase orders.

2 unchanged sentences

(“Shaw”), a significant consumer of caprolactam and Nylon 6 resin, to whom we sell under a long-term agreement.

For the three months ended March 31, 2026 and 2025, the Company's sales to Shaw were 9 % and 10 % of our total sales, respectively.

The Company's revenue by product line, and related approximate percentage of total sales, for the three months ended March 31, 2026 and 2025 were as follows:

For the three months ended June 30, 2026 and 2025, the Company's sales to Shaw were 8 % and 9 % of our total sales, respectively.

For each of the six months ended June 30, 2026 and 2025, the Company's sales to Shaw were 9 % of our total sales.

The Company's revenue by product line, and related approximate percentage of total sales, for the three and six months ended June 30, 2026 and 2025 were as follows:

Three Months Ended

June 30, Six Months Ended

2026 2025 2026 2025

Nylon $ 100,218 24 % $ 79,503 20 % $ 188,685 23 % $ 167,871 21 %

3 unchanged sentences

Total $ 421,284 100 % $ 410,022 100 % $ 825,468 100 % $ 787,813 100 %

The Company's revenues by geographic area, and related approximate percentage of total sales, for the three months ended March 31, 2026 and 2025 were as follows:

The Company's revenues by geographic area, and related approximate percentage of total sales, for the three and six months ended June 30, 2026 and 2025 were as follows:

Three Months Ended

June 30, Six Months Ended

2026 2025 2026 2025

United States $ 354,322 84 % $ 358,671 87 % $ 690,319 84 % $ 679,118 86 %

1 unchanged sentence

Total $ 421,284 100 % $ 410,022 100 % $ 825,468 100 % $ 787,813 100 %

* Predominantly Latin America, EMEA and Canada.

* Predominantly Latin America, Europe, Middle East and Africa (EMEA) and Canada.

Deferred Income and Customer Advances

The Company defers revenues when cash payments are received in advance of our performance.

Below is a roll-forward of Deferred income and customer advances for the three months ended March 31, 2026:

Below is a roll-forward of Deferred income and customer advances for the six months ended June 30, 2026:

Opening balance January 1, 2026 $ 14,536

1 unchanged sentence

Less amounts recognized in revenues ( 12,556 )

Ending balance March 31, 2026 $ 11,303

Ending balance June 30, 2026 $ 1,980

The Company expects to recognize as revenue the June 30, 2026 ending balance of Deferred income and customer advances which are predominantly driven by our ammonium sulfate pre-buy program, within one year or less.

Earnings Per Share

The computation of basic and diluted earnings per share ("EPS") is based on Net income (loss) divided by the basic weighted average number of common shares outstanding an d, where appropriate, dilu ted weighted average number of common shares outstanding, respectively.

The details of the basic and diluted EPS calculations for the three and six months ended June 30, 2026 and 2025 were as follows:

ADVANSIX INC.

1 unchanged sentence

(Dollars in thousands, except share and per share amounts and as otherwise noted)

The Company expects to recognize as revenue the March 31, 2026 ending balance of Deferred income and customer advances which are predominantly driven by our ammonium sulfate pre-buy program, within one year or less.

Earnings Per Share

The details of the basic and diluted EPS calculations for the three months ended March 31, 2026 and 2025 were as follows:

Three Months Ended

June 30, Six Months Ended

2026 2025 2026 2025

Net income (loss) $ 3,248 $ 31,371 $ ( 12,298 ) $ 54,715

6 unchanged sentences

Where appropriate, the diluted EPS calculations exclude the effect of stock options when the options’ assumed proceeds exceed the average market price of the common shares during the period.

The anti-dilutive common stock equivalents outstanding at the three months ended March 31, 2026 and 2025 were as follows:

The anti-dilutive common stock equivalents outstanding at the three and six months ended June 30, 2026 and 2025 were as follows:

Three Months Ended

June 30, Six Months Ended

2026 2025 2026 2025

Options and stock equivalents 642,061 1,005,749 1,040,112 948,963

Dividend activity for the three months ended March 31, 2026 and 2025 was as follows:

Dividend activity for the three and six months ended June 30, 2026 and 2025 was as follows:

Three Months Ended

June 30, Six Months Ended

2026 2025 2026 2025

Cash dividends declared per share $ 0.16 $ 0.16 $ 0.32 $ 0.32

17 unchanged sentences

Total inventories $ 194,145 $ 236,495

Substantially all of the Company’s inventories at March 31, 2026 and December 31, 2025 are valued at the lower of cost or market using the last-in, first-out (“LIFO”) method.

However, approximately 5 % was valued at average cost using the first-in, first-out (“FIFO”) method at March 31, 2026.

The excess of replacement cost over the carrying value of total inventories subject to LIFO was $ 68.2 million and $ 61.3 million at March 31, 2026 and December 31, 2025, respectively.

Substantially all of the Company’s inventories at June 30, 2026 and December 31, 2025 are valued at the lower of cost or market using the last-in, first-out (“LIFO”) method.

However, approximately 6 % was valued at average cost using the first-in, first-out (“FIFO”) method at June 30, 2026.

The excess of replacement cost over the carrying value of total inventories subject to LIFO was $ 79.4 million and $ 61.3 million at June 30, 2026 and December 31, 2025, respectively.

The Company determines if an arrangement is a lease at inception.

3 unchanged sentences

Three Months Ended

June 30, Six Months Ended

2026 2025 2026 2025

Finance lease cost:

5 unchanged sentences

Total lease cost $ 15,451 $ 15,106 $ 30,906 $ 29,275

As of March 31, 2026, we have no additional operating or finance leases that have not yet commenced.

As of June 30, 2026, we have no additional operating or finance leases that have not yet commenced.

Goodwill and Intangible Assets

1 unchanged sentence

Customer relationships and trade-names are amortized on a straight-line basis over their expected useful lives of 15 to 20 years and 5 years, respectively.

There was no change in the carrying amount of goodwill for the three months ended March 31, 2026.

To determine if goodwill is potentially impaired, we may perform either a qualitative assessment to determine whether it is more likely than not that the fair value is less than the carrying value or a quantitative assessment.

There was no change in the carrying amount of goodwill for the three or six months ended June 30, 2026.

To determine if goodwill is potentially impaired, we may perform either a qualitative or quantitative assessment to determine whether it is more likely than not that the fair value is less than the carrying value.

The Company most recently performed a qualitative assessment in the fourth quarter of 2025 whereby we considered the enterprise value from the previous 2023 quantitative test (including the underlying excess fair value over carrying value), macroeconomic conditions (including changes in interest and discount rates), industry and market considerations, recent and projected financial performance, as well as other factors.

3 unchanged sentences

(Dollars in thousands, except share and per share amounts and as otherwise noted)

Our qualitative analysis reflects our best estimates of the impacts of the cyclical nature of the industries in which we operate, as well as the cycles of fluctuating supply and demand for each of our products resulting in changes in selling prices and margins.

In the quarter ended June 30, 2026, the Company identified certain events and circumstances, specifically a sustained decline in market capitalization, that required an interim evaluation of whether it was more likely than not that its fair value was less than its carrying value.

Accordingly, the Company performed a quantitative goodwill impairment assessment during the quarter ended June 30, 2026.

The fair value of the reporting unit was determined using a combination of an income approach, based on discounted cash flows, and a market approach, utilizing comparable public company multiples.

Under the income approach, the fair value of the reporting unit is estimated based on the present value of the projected future cash flows.

Management's cash flow projections for the reporting unit included significant judgments and assumptions, including revenue growth rate, EBITDA margin, future capital expenditures, market participants cost synergies and discount rate.

Under the market approach, management uses selected financial information of publicly-traded companies that compare to the reporting unit to derive a market-based multiple.

The Company considered the difference between net book value and market capitalization in assessing the reasonableness of the estimated fair value of its reporting unit.

Based on the results of the quantitative assessment completed during the second quarter, the Company concluded that the estimated fair value of the reporting unit was in excess of its carrying value, resulting in no impairment.

Our qualitative and quantitative assessment reflects our best estimates of the impacts of the cyclical nature of the industries in which we operate, as well as the cycles of fluctuating supply and demand for each of our products resulting in changes in selling prices and margins.

It is possible that in the future there may be changes in industry trends, estimates and assumptions, including the timing and amount of future cash flows, margins, growth rates, market participant assumptions, comparable benchmark companies and related multiples and discount rates, which could impact estimates of fair value.

2 unchanged sentences

Intangible assets subject to amortization were as follows:

March 31, 2026 December 31, 2025

June 30, 2026 December 31, 2025

Gross Carrying Amount Accumulated Amortization Net Book Value Gross Carrying Amount Accumulated Amortization Net Book Value

3 unchanged sentences

Total $ 56,371 $ ( 17,801 ) $ 38,570 $ 56,371 $ ( 16,276 ) $ 40,095

For each of the three months ended March 31, 2026 and March 31, 2025, the Company recorded amortization expense on intangible assets of $ 0.8 million.

For each of the three months ended June 30, 2026 and June 30, 2025, the Company recorded amortization expense on intangible assets of $ 0.8 million.

For each of the six months ended June 30, 2026 and June 30, 2025, the Company recorded amortization expense on intangible assets of $ 1.5 million.

Commitments and Contingencies

4 unchanged sentences

Considering the Company’s past experience and existing accruals, the Company does not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on the Company’s consolidated financial position or results of operations.

Potential liabilities are subject to change due to new developments, changes in settlement strategy or the impact of evidentiary requirements, which could cause the Company to pay damage awards or settlements (or become subject to equitable remedies) that could have a material adverse effect on the Company’s consolidated results of operations, balance sheet and/or operating cash flows in the periods recognized or paid.

ADVANSIX INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts and as otherwise noted)

that could have a material adverse effect on the Company’s consolidated results of operations, balance sheet and/or operating cash flows in the periods recognized or paid.

We assumed from Honeywell International Inc.

2 unchanged sentences

Although we have ongoing environmental remedial obligations at certain of our facilities, in the past three years, the associated remediation costs have not been material, and we do not expect our known remediation costs to have a material adverse effect on the Company's consolidated financial position or results of operations.

The provision (benefit) for income taxes was ($ 5.1 million) and $ 5.6 million for the three months ended March 31, 2026 and 2025, respectively, resulting in an effective tax rate of 24.8 % and 19.3 %, respectively.

ADVANSIX INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts and as otherwise noted)

The provision for income taxes was $ 3.4 million and $ 0.3 million for the three months ended June 30, 2026 and 2025, respectively, resulting in an effective tax rate of 51.2 % and 0.9 %, respectively.

The provision (benefit) for income taxes was ($ 1.7 million) and $ 5.9 million for the six months ended June 30, 2026 and 2025, respectively, resulting in an effective tax rate of 12.3 % and 9.7 %, respectively.

The Company’s provision (benefit) for income taxes in interim periods is computed by applying an estimated annual effective tax rate against Income (loss) before taxes for the period in addition to recording any tax effects of discrete items for the quarter.

The Company’s effective tax rate for the three months ended March 31, 2026 and 2025 differed from the U.S.

federal statutory rate due to state taxes and executive compensation deduction limitations which generally increase the rate, offset by research tax credits and the foreign-derived deduction eligible income (FDDEI) deduction (formerly known as the foreign-derived intangible income (FDII) deduction) that generally decrease the rate.

During the three months ended March 31, 2025, discrete tax adjustments recorded in the quarter related to Internal Revenue Code (IRC) Section 45Q tax credits of $ 1.8 million, offset slightly by state tax legislation changes, resulted in a net 5.8 % decrease on the rate.

The Company’s effective tax rates for the three and six months ended June 30, 2026 and 2025 differed from the U.S.

federal statutory rate primarily due to state taxes and executive compensation deduction limitations which generally increase the rate, offset by research tax credits that generally decrease the rate.

These adjustments have the inverse impact on the effective tax rate in periods with a loss before taxes.

Changes in our forecasted earnings and taxable income between the first and second quarter have impacted our effective tax rate for the three and six months ended June 30, 2026.

Additionally, discrete tax adjustments recorded in the first and second quarter of 2025 related to Internal Revenue Code (IRC) Section 45Q tax credits of $ 1.8 million and $ 7.9 million, respectively, offset slightly by state tax legislation changes, resulted in a net 24.7 % and 15.7 % decrease in the rate for the three and six months ended June 30, 2025, respectively.

On July 4, 2025, the One Big Beautiful Bill Act (the "Act") was enacted into law which includes numerous tax provisions affecting businesses, including the reinstatement of full expensing of domestic research and experimental expenditures, modification of the limitation on business interest and making permanent full expensing for certain business property.

Several of the major business provisions in the Act became effective in 2025 while other business tax changes are effective for the 2026 tax year.

The major business provisions in the Act reduced our cash taxes in 2025 and are expected to reduce our cash taxes in 2026 and future periods.

The major business provisions in the Act reduced our cash taxes in 2025 and are expected to reduce our cash taxes in future periods.

Supplier Finance Programs

3 unchanged sentences

All related agreements are terminable by either party upon at least 30 days’ notice.

The total amount due to the financial intermediary to settle supplier invoices under the Company's supply chain finance program was approximately $ 11.0 million as of March 31, 2026 and approximately $ 9.0 million as of December 31, 2025.

The total amount due to the financial intermediary to settle supplier invoices under the Company's supply chain finance program was approximately $ 12.2 million as of June 30, 2026 and approximately $ 9.0 million as of December 31, 2025.

These amounts outstanding are included in Accounts payable .

6 unchanged sentences

Additionally, the Company’s operating results, which are evaluated regularly to make decisions about resource allocation and performance assessment by the chief operating decision maker ("CODM"), our CEO and President, are on a consolidated basis.

ADVANSIX INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts and as otherwise noted)

The chemical manufacturing segment derives its revenues by innovating and delivering essential products in the industries of nylon solutions, plant nutrients, and chemical intermediates to its customers in a wide variety of end markets and applications, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics.

5 unchanged sentences

Significant expense information reviewed by the CODM was as follows (in thousands):

ADVANSIX INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except share and per share amounts and as otherwise noted)

Three Months Ended March 31,

Three Months Ended June 30, Six Months Ended June 30,

2026 2025 2026 2025

Revenue $ 421,284 $ 410,022 $ 825,468 $ 787,813

4 unchanged sentences

Other segment items ** 7,142 4,470 6,817 13,348

Segment net income $ ( 15,546 ) $ 23,344

Segment net income (loss) $ 3,248 $ 31,371 $ ( 12,298 ) $ 54,715

*Variable costs of goods sold includes the raw material costs associated with volumes sold during the period as well as insurance settlement proceeds, when applicable.

1 unchanged sentence

Subsequent Events

As announced on May 8, 2026, the Board declared a quarterly cash dividend of $ 0.16 per share on the Company's common stock, payable on June 2, 2026 to stockholders of record as of the close of business on May 19, 2026.

As announced on August 7, 2026, the Board declared a quarterly cash dividend of $ 0.16 per share on the Company's common stock, payable on September 1, 2026 to stockholders of record as of the close of business on August 18, 2026.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1. Financial Statements